The global pharmaceutical industry is experiencing a shift towards Chinese innovation, with 30% of major pharma deals now involving Chinese partnerships. American pharmaceutical companies are increasingly engaging with Chinese firms for their cost-effective, cutting-edge research and drug discovery capabilities. This trend occurs

China’s strong presence in drug innovation and manufacturing is transforming the pharmaceutical industry. About 30% of major Big Pharma deals in 2024 involve Chinese firms, rising sharply from nearly zero five years ago. U.S. pharmaceutical companies are entering partnerships with Chinese companies

Will Semiconductor Co. is a key player in the semiconductor industry, with 85.5% of its operations focused on the design and sale of microchips. The mobile phone market consumes 50% of their semiconductor output, while 30% is directed to automotive electronics. A